The non-invasive serum biomarker soluble Axl accurately detects advanced liver fibrosis and cirrhosis.

MLA

Staufer, Katharina, et al. “The Non-Invasive Serum Biomarker Soluble Axl Accurately Detects Advanced Liver Fibrosis and Cirrhosis.” Cell Death & Disease, vol. 8, no. 10, Oct. 2017, p. e3135. EBSCOhost, https://doi.org/10.1038/cddis.2017.554.

APA

Staufer, K., Dengler, M., Huber, H., Marculescu, R., Stauber, R., Lackner, C., Dienes, H.-P., Kivaranovic, D., Schachner, C., Zeitlinger, M., Wulkersdorfer, B., Rauch, P., Prager, G., Trauner, M., & Mikulits, W. (2017). The non-invasive serum biomarker soluble Axl accurately detects advanced liver fibrosis and cirrhosis. Cell Death & Disease, 8(10), e3135. https://doi.org/10.1038/cddis.2017.554

Chicago

Staufer, Katharina, Mirko Dengler, Heidemarie Huber, Rodrig Marculescu, Rudolf Stauber, Carolin Lackner, Hans-Peter Dienes, et al. 2017. “The Non-Invasive Serum Biomarker Soluble Axl Accurately Detects Advanced Liver Fibrosis and Cirrhosis.” Cell Death & Disease 8 (10): e3135. doi:10.1038/cddis.2017.554.